ANDA 79093, held by Tp Anda Holdings. Nabumetone.
As of Nov 15, 2026, ANDA 79093 (Nabumetone), held by Tp Anda Holdings, was first approved by FDA on Feb 27, 2009, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 27, 2009 | Original application | Approved |
| Nabumetone500MG · tablet;oral | Nabumetone | Discontinued |
| Nabumetone750MG · tablet;oral | Nabumetone | Discontinued |
| Nov 21, 2024 | Supplement 3Labeling · Standard review | Approved | None posted |
| Apr 28, 2021 | Supplement 2Labeling · Standard review | Approved | None posted |
| Aug 8, 2016 | Supplement 1Labeling · Standard review | Approved | None posted |
| Feb 27, 2009 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters